Akari Therapeutics

Akari Therapeutics is a development stage biopharmaceutical company that is developing Coversin for complement-mediated disorders. Deerfield led a $75 million financing to fund the clinical development of Coversin across several therapeutic areas, including hematology, nephrology and neurology.